脑部放疗，上午比下午敏感许多！
`" G7 _% ?1 a, q% v4 z! K' A9 F( O) P( g
( W: B/ t7 \/ u% [2 C$ CCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9. v2 R7 H" W3 X# k+ n" B
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?6 }& i& P& K; p7 X) B
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
D% C4 U) I0 T. K9 p5 M& NSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
, o+ A/ v; J" a2 H6 | }; ^) S& Y$ \. G
Abstract% E3 z# e# P2 R y$ R p/ i
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
/ E: d4 y% ^8 Y/ V& M( b* ^0 w. y6 U7 x @* [- ]- i4 @! O+ Z
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
, U$ e+ h0 U/ q/ n0 {3 B
- M8 {7 X! c4 W8 C& ^6 {RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
$ j( X/ G# v+ {) s0 T: n9 x/ O; v) L3 j, v" k P4 i
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
9 ?% n/ J* C: v3 ~7 I& U+ I; W1 u1 X, B/ O# k8 v+ y
|
显身卡
